title: Blood, subject 31720865, hours since injury 3

source_name: Subject 31720865, hours since injury 3


title: Blood, subject 32329957, hours since injury 88.4

status: Public on Mar 27 2012

type: RNA

city: Boston

first: Wenzhong Xiao

state: MA

address: 55 Fruit Street, GRV 1302

department: Department of Surgery

country: USA

institute: Massachusetts General Hospital

hyb_protocol: Following fragmentation, 10 ug of cRNA was hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix GeneChip Fluidics Station FS 4500, and used the standard solutions recommended by Affymetrix

scan_protocol: GeneChips were scanned using the Affymetrix Scanner G3000

data_processing: Affymetrix Power Tools version 1.8.6 RMA model

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Subject 32329957, hours since injury 88.4

label_protocol: Biotinylated cRNA was prepared according to the standard Affymetrix protocol from 2 ug RNA (Expression Analysis Technical Manual rev 3, 2002, Affymetrix)

extract_protocol: Total RNA was purified using the Rneasy RNA Isolation kit standard protocol (Qiagen, Valencia, CA)

treatment_protocol: White blood cells were separated using a modified buffy coat isolation and red blood cell lysis method. This protocol recovers the plasma fraction, lyses RBCs, and allows recovery of the white blood cell fraction, eliminating the need to recover the buffy coat interfacial layer.

tag: tissue

value: White Blood Cells

tag: Sex

value: F

tag: age


title: Blood, subject 31549646, hours since injury 170.3

source_name: Subject 31549646, hours since injury 170.3

value: M


title: Blood, subject 32406125, hours since injury 41.8

source_name: Subject 32406125, hours since injury 41.8


title: Blood, subject 31316621, hours since injury 9.1

source_name: Subject 31316621, hours since injury 9.1


title: Blood, subject 31316621, hours since injury 33.2

source_name: Subject 31316621, hours since injury 33.2


title: Blood, subject 309805, hours since injury 29.7

source_name: Subject 309805, hours since injury 29.7


title: Blood, subject 31549646, hours since injury 26.3

source_name: Subject 31549646, hours since injury 26.3


title: Blood, subject 31022812, hours since injury 34.2

source_name: Subject 31022812, hours since injury 34.2


title: Blood, subject 31316621, hours since injury 106.4

source_name: Subject 31316621, hours since injury 106.4


title: Blood, subject 309805, hours since injury 6.8

source_name: Subject 309805, hours since injury 6.8


title: Blood, subject 31316621, hours since injury 203.3

source_name: Subject 31316621, hours since injury 203.3


title: Blood, subject 31022812, hours since injury 12

source_name: Subject 31022812, hours since injury 12


title: Blood, subject 30822033, hours since injury 8.8

source_name: Subject 30822033, hours since injury 8.8


title: Blood, subject 30781522, hours since injury 82.4

source_name: Subject 30781522, hours since injury 82.4


title: Blood, subject 30822033, hours since injury 38.8

source_name: Subject 30822033, hours since injury 38.8


title: Blood, subject 31549646, hours since injury 10.7

source_name: Subject 31549646, hours since injury 10.7


title: Blood, subject 31022812, hours since injury 105.8

source_name: Subject 31022812, hours since injury 105.8


title: Blood, subject 309805, hours since injury 175.1

source_name: Subject 309805, hours since injury 175.1


title: Blood, subject 30822033, hours since injury 181.7

source_name: Subject 30822033, hours since injury 181.7


title: Blood, subject 30822033, hours since injury 110.4

source_name: Subject 30822033, hours since injury 110.4


title: Blood, subject 309805, hours since injury 103.5

source_name: Subject 309805, hours since injury 103.5


title: Blood, subject 30781522, hours since injury 153.5

source_name: Subject 30781522, hours since injury 153.5


title: Blood, subject 30781522, hours since injury 33.8

source_name: Subject 30781522, hours since injury 33.8


title: Blood, subject 30726204, hours since injury 709.5

source_name: Subject 30726204, hours since injury 709.5


title: Blood, subject 30726204, hours since injury 374.9

source_name: Subject 30726204, hours since injury 374.9


title: Blood, subject 30726204, hours since injury 37.2

source_name: Subject 30726204, hours since injury 37.2


title: Blood, subject 30781522, hours since injury 10.8

source_name: Subject 30781522, hours since injury 10.8


title: Blood, subject 30726204, hours since injury 225.3

source_name: Subject 30726204, hours since injury 225.3


title: Blood, subject 30726204, hours since injury 543.9

source_name: Subject 30726204, hours since injury 543.9


title: Blood, subject 30301932, hours since injury 88.2

source_name: Subject 30301932, hours since injury 88.2


title: Blood, subject 30288439, hours since injury 111.3

source_name: Subject 30288439, hours since injury 111.3


title: Blood, subject 30301932, hours since injury 10

source_name: Subject 30301932, hours since injury 10


title: Blood, subject 30288439, hours since injury 53.6

source_name: Subject 30288439, hours since injury 53.6


title: Blood, subject 30301932, hours since injury 183.3

source_name: Subject 30301932, hours since injury 183.3


title: Blood, subject 30288439, hours since injury 160.5

source_name: Subject 30288439, hours since injury 160.5


title: Blood, subject 2976266, hours since injury 7.8

source_name: Subject 2976266, hours since injury 7.8


title: Blood, subject 29876571, hours since injury 4.3

source_name: Subject 29876571, hours since injury 4.3


title: Blood, subject 30726204, hours since injury 11.7

source_name: Subject 30726204, hours since injury 11.7


title: Blood, subject 30288439, hours since injury 328.5

source_name: Subject 30288439, hours since injury 328.5


title: Blood, subject 29738949, hours since injury 175.8

source_name: Subject 29738949, hours since injury 175.8


title: Blood, subject 29876571, hours since injury 179.4

source_name: Subject 29876571, hours since injury 179.4


title: Blood, subject 2976266, hours since injury 521.8

source_name: Subject 2976266, hours since injury 521.8


title: Blood, subject 29738949, hours since injury 11.2

source_name: Subject 29738949, hours since injury 11.2


title: Blood, subject 2976266, hours since injury 111.8

source_name: Subject 2976266, hours since injury 111.8


title: Blood, subject 29670554, hours since injury 199.8

source_name: Subject 29670554, hours since injury 199.8


title: Blood, subject 29670554, hours since injury 31.9

source_name: Subject 29670554, hours since injury 31.9


title: Blood, subject 29738949, hours since injury 31.8

source_name: Subject 29738949, hours since injury 31.8


title: Blood, subject 2976266, hours since injury 40

source_name: Subject 2976266, hours since injury 40


title: Blood, subject 29738949, hours since injury 104.8

source_name: Subject 29738949, hours since injury 104.8


title: Blood, subject 2976266, hours since injury 353.3

source_name: Subject 2976266, hours since injury 353.3


title: Blood, subject 29670554, hours since injury 104

source_name: Subject 29670554, hours since injury 104


title: Blood, subject 30301932, hours since injury 42.3

source_name: Subject 30301932, hours since injury 42.3


title: Blood, subject 29670554, hours since injury 12.3

source_name: Subject 29670554, hours since injury 12.3


title: Blood, subject 2976266, hours since injury 183.5

source_name: Subject 2976266, hours since injury 183.5


title: Blood, subject 29663633, hours since injury 7.7

source_name: Subject 29663633, hours since injury 7.7


title: Blood, subject 29663633, hours since injury 64.1

source_name: Subject 29663633, hours since injury 64.1


title: Blood, subject 32171289, hours since injury 640.3

source_name: Subject 32171289, hours since injury 640.3


title: Blood, subject 32171289, hours since injury 88.2

source_name: Subject 32171289, hours since injury 88.2


title: Blood, subject 29358205, hours since injury 43.8

source_name: Subject 29358205, hours since injury 43.8


title: Blood, subject 29358205, hours since injury 11.7

source_name: Subject 29358205, hours since injury 11.7


title: Blood, subject 30288439, hours since injury 11.6

source_name: Subject 30288439, hours since injury 11.6


title: Blood, subject 29663633, hours since injury 15.9

source_name: Subject 29663633, hours since injury 15.9


title: Blood, subject 29060513, hours since injury 518.3

source_name: Subject 29060513, hours since injury 518.3


title: Blood, subject 29358205, hours since injury 88

source_name: Subject 29358205, hours since injury 88


title: Blood, subject 28485446, hours since injury 350.3

source_name: Subject 28485446, hours since injury 350.3


title: Blood, subject 28485446, hours since injury 11.8

source_name: Subject 28485446, hours since injury 11.8


title: Blood, subject 29060513, hours since injury 350.3

source_name: Subject 29060513, hours since injury 350.3


title: Blood, subject 29080250, hours since injury 39.1

source_name: Subject 29080250, hours since injury 39.1


title: Blood, subject 29060513, hours since injury 12.3

source_name: Subject 29060513, hours since injury 12.3


title: Blood, subject 29060513, hours since injury 38.1

source_name: Subject 29060513, hours since injury 38.1


title: Blood, subject 28808962, hours since injury 51.8

source_name: Subject 28808962, hours since injury 51.8


title: Blood, subject 28808962, hours since injury 531.1

source_name: Subject 28808962, hours since injury 531.1


title: Blood, subject 28485446, hours since injury 518

source_name: Subject 28485446, hours since injury 518


title: Blood, subject 28808962, hours since injury 6.8

source_name: Subject 28808962, hours since injury 6.8


title: Blood, subject 29060513, hours since injury 181.6

source_name: Subject 29060513, hours since injury 181.6


title: Blood, subject 29080250, hours since injury 9.4

source_name: Subject 29080250, hours since injury 9.4


title: Blood, subject 28808962, hours since injury 199.2

source_name: Subject 28808962, hours since injury 199.2


title: Blood, subject 28485446, hours since injury 181.2

source_name: Subject 28485446, hours since injury 181.2


title: Blood, subject 29060513, hours since injury 110.4

source_name: Subject 29060513, hours since injury 110.4


title: Blood, subject 28485446, hours since injury 42

source_name: Subject 28485446, hours since injury 42


title: Blood, subject 28808962, hours since injury 98.7

source_name: Subject 28808962, hours since injury 98.7


title: Blood, subject 28808962, hours since injury 363.7

source_name: Subject 28808962, hours since injury 363.7


title: Blood, subject 28808962, hours since injury 700

source_name: Subject 28808962, hours since injury 700


title: Blood, subject 28385224, hours since injury 175.8

source_name: Subject 28385224, hours since injury 175.8


title: Blood, subject 28385224, hours since injury 129.5

source_name: Subject 28385224, hours since injury 129.5


title: Blood, subject 28385224, hours since injury 6.6

source_name: Subject 28385224, hours since injury 6.6


title: Blood, subject 28385224, hours since injury 30.8

source_name: Subject 28385224, hours since injury 30.8


title: Blood, subject 28332176, hours since injury 40

source_name: Subject 28332176, hours since injury 40


title: Blood, subject 28332176, hours since injury 9.4

source_name: Subject 28332176, hours since injury 9.4


title: Blood, subject 28332176, hours since injury 112.4

source_name: Subject 28332176, hours since injury 112.4


title: Blood, subject 28128372, hours since injury 6.2

source_name: Subject 28128372, hours since injury 6.2


title: Blood, subject 28128372, hours since injury 96.6

source_name: Subject 28128372, hours since injury 96.6


title: Blood, subject 28105148, hours since injury 5

source_name: Subject 28105148, hours since injury 5


title: Blood, subject 28105148, hours since injury 96.8

source_name: Subject 28105148, hours since injury 96.8


title: Blood, subject 28105148, hours since injury 362.5

source_name: Subject 28105148, hours since injury 362.5


title: Blood, subject 27820153, hours since injury 178.5

source_name: Subject 27820153, hours since injury 178.5


title: Blood, subject 28105148, hours since injury 170.5

source_name: Subject 28105148, hours since injury 170.5


title: Blood, subject 28128372, hours since injury 33.5

source_name: Subject 28128372, hours since injury 33.5


title: Blood, subject 27683661, hours since injury 700.1

source_name: Subject 27683661, hours since injury 700.1


title: Blood, subject 28105148, hours since injury 503.5

source_name: Subject 28105148, hours since injury 503.5


title: Blood, subject 27820153, hours since injury 34.8

source_name: Subject 27820153, hours since injury 34.8


title: Blood, subject 27683661, hours since injury 529.8

source_name: Subject 27683661, hours since injury 529.8


title: Blood, subject 27683661, hours since injury 362.8

source_name: Subject 27683661, hours since injury 362.8


title: Blood, subject 28128372, hours since injury 144.8

source_name: Subject 28128372, hours since injury 144.8


title: Blood, subject 27820153, hours since injury 11.3

source_name: Subject 27820153, hours since injury 11.3


title: Blood, subject 27820153, hours since injury 82.5

source_name: Subject 27820153, hours since injury 82.5


title: Blood, subject 27683661, hours since injury 26.2

source_name: Subject 27683661, hours since injury 26.2


title: Blood, subject 30726204, hours since injury 109.9

source_name: Subject 30726204, hours since injury 109.9


title: Blood, subject 27683661, hours since injury 194

source_name: Subject 27683661, hours since injury 194


title: Blood, subject 28128372, hours since injury 312.5

source_name: Subject 28128372, hours since injury 312.5


title: Blood, subject 28105148, hours since injury 23.8

source_name: Subject 28105148, hours since injury 23.8


title: Blood, subject 274441, hours since injury 97

source_name: Subject 274441, hours since injury 97


title: Blood, subject 27820153, hours since injury 370.3

source_name: Subject 27820153, hours since injury 370.3


title: Blood, subject 27683661, hours since injury 6.5

source_name: Subject 27683661, hours since injury 6.5


title: Blood, subject 274441, hours since injury 169.8

source_name: Subject 274441, hours since injury 169.8


title: Blood, subject 274441, hours since injury 28.1

source_name: Subject 274441, hours since injury 28.1


title: Blood, subject 26657616, hours since injury 6

source_name: Subject 26657616, hours since injury 6


title: Blood, subject 26952856, hours since injury 183.8

source_name: Subject 26952856, hours since injury 183.8


title: Blood, subject 26657616, hours since injury 24.5

source_name: Subject 26657616, hours since injury 24.5


title: Blood, subject 26671858, hours since injury 20.5

source_name: Subject 26671858, hours since injury 20.5


title: Blood, subject 26952856, hours since injury 9

source_name: Subject 26952856, hours since injury 9


title: Blood, subject 26293037, hours since injury 80.5

source_name: Subject 26293037, hours since injury 80.5


title: Blood, subject 26952856, hours since injury 41.5

source_name: Subject 26952856, hours since injury 41.5


title: Blood, subject 26952856, hours since injury 349.9

source_name: Subject 26952856, hours since injury 349.9


title: Blood, subject 26952856, hours since injury 109.8

source_name: Subject 26952856, hours since injury 109.8


title: Blood, subject 26671858, hours since injury 8.6

source_name: Subject 26671858, hours since injury 8.6


title: Blood, subject 26657616, hours since injury 94.1

source_name: Subject 26657616, hours since injury 94.1


title: Blood, subject 26293037, hours since injury 35.7

source_name: Subject 26293037, hours since injury 35.7


title: Blood, subject 274441, hours since injury 4.5

source_name: Subject 274441, hours since injury 4.5


title: Blood, subject 26293037, hours since injury 9.8

source_name: Subject 26293037, hours since injury 9.8


title: Blood, subject 26259680, hours since injury 90

source_name: Subject 26259680, hours since injury 90


title: Blood, subject 26671858, hours since injury 163

source_name: Subject 26671858, hours since injury 163


title: Blood, subject 26259680, hours since injury 3.9

source_name: Subject 26259680, hours since injury 3.9


title: Blood, subject 26671858, hours since injury 120

source_name: Subject 26671858, hours since injury 120


title: Blood, subject 26259680, hours since injury 160.6

source_name: Subject 26259680, hours since injury 160.6


title: Blood, subject 26293037, hours since injury 176.9

source_name: Subject 26293037, hours since injury 176.9


title: Blood, subject 26020260, hours since injury 75.2

source_name: Subject 26020260, hours since injury 75.2


title: Blood, subject 26657616, hours since injury 166.2

source_name: Subject 26657616, hours since injury 166.2


title: Blood, subject 26020260, hours since injury 25.5

source_name: Subject 26020260, hours since injury 25.5


title: Blood, subject 26259680, hours since injury 18.2

source_name: Subject 26259680, hours since injury 18.2


title: Blood, subject 26020260, hours since injury 170.3

source_name: Subject 26020260, hours since injury 170.3


title: Blood, subject 25993337, hours since injury 704.2

source_name: Subject 25993337, hours since injury 704.2


title: Blood, subject 25993337, hours since injury 7.7

source_name: Subject 25993337, hours since injury 7.7


title: Blood, subject 25980713, hours since injury 207.3

source_name: Subject 25980713, hours since injury 207.3


title: Blood, subject 25598097, hours since injury 9.7

source_name: Subject 25598097, hours since injury 9.7


title: Blood, subject 25980713, hours since injury 36.1

source_name: Subject 25980713, hours since injury 36.1


title: Blood, subject 25993337, hours since injury 225

source_name: Subject 25993337, hours since injury 225


title: Blood, subject 25518540, hours since injury 491.8

source_name: Subject 25518540, hours since injury 491.8


title: Blood, subject 28485446, hours since injury 109.9

source_name: Subject 28485446, hours since injury 109.9


title: Blood, subject 25598097, hours since injury 31.6

source_name: Subject 25598097, hours since injury 31.6


title: Blood, subject 25598097, hours since injury 199

source_name: Subject 25598097, hours since injury 199


title: Blood, subject 25993337, hours since injury 369.4

source_name: Subject 25993337, hours since injury 369.4


title: Blood, subject 25518540, hours since injury 36.6

source_name: Subject 25518540, hours since injury 36.6


title: Blood, subject 25993337, hours since injury 536.1

source_name: Subject 25993337, hours since injury 536.1


title: Blood, subject 25980713, hours since injury 11.8

source_name: Subject 25980713, hours since injury 11.8


title: Blood, subject 25518540, hours since injury 154.6

source_name: Subject 25518540, hours since injury 154.6


title: Blood, subject 25993337, hours since injury 32.4

source_name: Subject 25993337, hours since injury 32.4


title: Blood, subject 25444954, hours since injury 9.9

source_name: Subject 25444954, hours since injury 9.9


title: Blood, subject 25518540, hours since injury 322.1

source_name: Subject 25518540, hours since injury 322.1


title: Blood, subject 25598097, hours since injury 102.8

source_name: Subject 25598097, hours since injury 102.8


title: Blood, subject 25993337, hours since injury 105

source_name: Subject 25993337, hours since injury 105


title: Blood, subject 25598097, hours since injury 393.3

source_name: Subject 25598097, hours since injury 393.3


title: Blood, subject 25444954, hours since injury 346.3

source_name: Subject 25444954, hours since injury 346.3


title: Blood, subject 25444954, hours since injury 41.9

source_name: Subject 25444954, hours since injury 41.9


title: Blood, subject 25499319, hours since injury 36

source_name: Subject 25499319, hours since injury 36


title: Blood, subject 25518540, hours since injury 11.4

source_name: Subject 25518540, hours since injury 11.4


title: Blood, subject 25499319, hours since injury 11.8

source_name: Subject 25499319, hours since injury 11.8


title: Blood, subject 25980713, hours since injury 88.8

source_name: Subject 25980713, hours since injury 88.8


title: Patient 420; stage IB; Neuroendocrine

city: Milwaukee

first: Yan

last: Lu

address: 8701 Watertown Plank Rd

institute: Medical College of Wisconsin

hyb_protocol: Fluorescently labelled cDNA PCR products were hybridized to Human v2 MicroRNA Expression BeadChips (Cat. no. MI-102–1024; Illumina), according to the protocols provided by the manufacturer.

scan_protocol: Standard Illumina scanning protocol

data_processing: The data were normalised using quantile normalisation algorithm

label: BIOTIN

source_name: Patient 420

label_protocol: Two hundred ng of total RNA from each sample were labeled and hybridized on Human v2 MicroRNA Expression BeadChips (Cat. no. MI-102–1024; Illumina), according to the manufacturers recommendations (Illumina MicroRNA Expression Profiling Assay Guide).

extract_protocol: Total RNA, including miRNA from FFPE lung cancer tissue, RNA was extracted with the Ambion RecoverAll kit (Applied Biosystems, Austin, TX). The recovered RNA was DNAse treated and the quantity and quality were evaluated using a Nanodrop ND-1000 (Thermo Scientific) with an inclusion criterion of A260/A280 ≥1.8.

tag: disease state

value: non-small cell lung cancer (NSCLC)

tag: patient id

tag: Stage

value: IB

tag: subtype

value: Neuroendocrine

tag: gender

value: Female


title: Patient 159; stage IA; SCC

source_name: Patient 159

value: IA

value: SCC


title: Patient 153_2; stage IB; AD

source_name: Patient 153_2

value: AD


title: Blood, subject 25444954, hours since injury 179

source_name: Subject 25444954, hours since injury 179


title: Patient 191; stage IB; AD

source_name: Patient 191


title: Patient 209; stage IA; AD

source_name: Patient 209


title: Blood, subject 26020260, hours since injury 4.2

source_name: Subject 26020260, hours since injury 4.2


title: Patient 46_2; stage IB; SCC

source_name: Patient 46_2


title: Patient 332; stage IA; AD

source_name: Patient 332

value: Male


title: Blood, subject 25518540, hours since injury 86.6

source_name: Subject 25518540, hours since injury 86.6


title: Patient 297_2; stage IB; SCC

source_name: Patient 297_2


title: Patient 24; stage IA; Broncho-alveolar

source_name: Patient 24

value: Broncho-alveolar


title: Patient 416; stage IB; SCC

source_name: Patient 416


title: Blood, subject 25335818, hours since injury 104.1

source_name: Subject 25335818, hours since injury 104.1


title: Patient 142; stage IA; AD

source_name: Patient 142


title: Blood, subject 25335818, hours since injury 38.8

source_name: Subject 25335818, hours since injury 38.8


title: Blood, subject 25444954, hours since injury 106.7

source_name: Subject 25444954, hours since injury 106.7


title: Patient 415; stage IA; AD

source_name: Patient 415


title: Patient 351; stage IA; AD

source_name: Patient 351


title: Blood, subject 25335818, hours since injury 344.4

source_name: Subject 25335818, hours since injury 344.4


title: Blood, subject 2471722, hours since injury 8.5

source_name: Subject 2471722, hours since injury 8.5


title: Patient 54_2; stage IB; AD

source_name: Patient 54_2


title: Blood, subject 2471722, hours since injury 343

source_name: Subject 2471722, hours since injury 343


title: Blood, subject 25335818, hours since injury 12.1

source_name: Subject 25335818, hours since injury 12.1


title: Blood, subject 27683661, hours since injury 98.1

source_name: Subject 27683661, hours since injury 98.1


title: Blood, subject 2471722, hours since injury 535.9

source_name: Subject 2471722, hours since injury 535.9


title: Blood, subject 2471722, hours since injury 175.4

source_name: Subject 2471722, hours since injury 175.4


title: Blood, subject 2471722, hours since injury 103.3

source_name: Subject 2471722, hours since injury 103.3


title: Patient 302_2; stage IB; SCC

source_name: Patient 302_2


title: Patient 189_2; stage IB; SCC

source_name: Patient 189_2


title: Patient 330_2; stage IA; SCC

source_name: Patient 330_2


title: Patient 306_2; stage IA; SCC

source_name: Patient 306_2


title: Patient 291; stage IA; Poorly differentiated

source_name: Patient 291

value: Poorly differentiated


title: Patient 333_2; stage IB; Adenosquamous

source_name: Patient 333_2

value: Adenosquamous


title: Patient 270; stage IA; AD

source_name: Patient 270


title: Patient 288_2; stage IB; SCC

source_name: Patient 288_2


title: Blood, subject 2433843, hours since injury 540

source_name: Subject 2433843, hours since injury 540


title: Blood, subject 2471722, hours since injury 679

source_name: Subject 2471722, hours since injury 679


title: Patient 312_2; stage IB; Adenosquamous

source_name: Patient 312_2


title: Blood, subject 2433843, hours since injury 372

source_name: Subject 2433843, hours since injury 372


title: Blood, subject 2433843, hours since injury 707.3

source_name: Subject 2433843, hours since injury 707.3


title: Patient 210; stage IA; SCC

source_name: Patient 210


title: Patient 227; stage IA; AD

source_name: Patient 227


title: Blood, subject 2471722, hours since injury 33.5

source_name: Subject 2471722, hours since injury 33.5


title: Patient 44; stage IA; Broncho-alveolar

source_name: Patient 44


title: Blood, subject 23853297, hours since injury 9.1

source_name: Subject 23853297, hours since injury 9.1


title: Blood, subject 2433843, hours since injury 3

source_name: Subject 2433843, hours since injury 3


title: Patient 30; stage IA; SCC

source_name: Patient 30


title: Patient 406_2; stage IB; Broncho-alveolar

source_name: Patient 406_2


title: Patient 424; stage IA; SCC

source_name: Patient 424


title: Blood, subject 23836873, hours since injury 501.1

source_name: Subject 23836873, hours since injury 501.1


title: Blood, subject 23836873, hours since injury 3.1

source_name: Subject 23836873, hours since injury 3.1


title: Blood, subject 23853297, hours since injury 312.7

source_name: Subject 23853297, hours since injury 312.7


title: Blood, subject 23836873, hours since injury 332.3

source_name: Subject 23836873, hours since injury 332.3


title: Blood, subject 23836873, hours since injury 23.6

source_name: Subject 23836873, hours since injury 23.6


title: Blood, subject 23836873, hours since injury 119.6

source_name: Subject 23836873, hours since injury 119.6


title: Patient 374; stage IA; SCC

source_name: Patient 374


title: Patient 370; stage IA; AD

source_name: Patient 370


title: Blood, subject 23853297, hours since injury 32.9

source_name: Subject 23853297, hours since injury 32.9


title: Patient 368; stage IA; AD

source_name: Patient 368


title: Blood, subject 23836873, hours since injury 187.8

source_name: Subject 23836873, hours since injury 187.8


title: Patient 5_2; stage IB; AD

source_name: Patient 5_2


title: Blood, subject 23853297, hours since injury 96.6

source_name: Subject 23853297, hours since injury 96.6


title: Blood, subject 23853297, hours since injury 482.5

source_name: Subject 23853297, hours since injury 482.5


title: Patient 307_2; stage IB; AD

source_name: Patient 307_2


title: Blood, subject 23237144, hours since injury 37.7

source_name: Subject 23237144, hours since injury 37.7


title: Blood, subject 22590163, hours since injury 6.9

source_name: Subject 22590163, hours since injury 6.9


title: Patient 342_2; stage IA; Neuroendocrine

source_name: Patient 342_2


title: Blood, subject 22987629, hours since injury 15.7

source_name: Subject 22987629, hours since injury 15.7


title: Blood, subject 22987629, hours since injury 4.4

source_name: Subject 22987629, hours since injury 4.4


title: Blood, subject 22590163, hours since injury 40.4

source_name: Subject 22590163, hours since injury 40.4


title: Blood, subject 22590163, hours since injury 209.5

source_name: Subject 22590163, hours since injury 209.5


title: Patient 194; stage IA; Broncho-alveolar

source_name: Patient 194


title: Blood, subject 23237144, hours since injury 13

source_name: Subject 23237144, hours since injury 13


title: Patient 34; stage IB; AD

source_name: Patient 34


title: Patient 319; stage IB; AD

source_name: Patient 319


title: Patient 364; stage IB; AD

source_name: Patient 364


title: Patient 32; stage IB; SCC

source_name: Patient 32


title: Patient 365; stage IA; AD

source_name: Patient 365


title: Patient 361; stage IA; AD

source_name: Patient 361


title: Blood, subject 22590163, hours since injury 113.2

source_name: Subject 22590163, hours since injury 113.2


title: Blood, subject 22244667, hours since injury 495.3

source_name: Subject 22244667, hours since injury 495.3


title: Blood, subject 22244667, hours since injury 327.3

source_name: Subject 22244667, hours since injury 327.3


title: Patient 359; stage IA; AD

source_name: Patient 359


title: Patient 311; stage IA; AD

source_name: Patient 311


title: Patient 421; stage IA; SCC

source_name: Patient 421


title: Blood, subject 22244667, hours since injury 641

source_name: Subject 22244667, hours since injury 641


title: Patient 122_2; stage IA; AD

source_name: Patient 122_2


title: Patient 335; stage IB; Poorly differentiated

source_name: Patient 335


title: Patient 182_2; stage IB; AD

source_name: Patient 182_2


title: Patient 185_2; stage IB; Broncho-alveolar

source_name: Patient 185_2


title: Blood, subject 22244667, hours since injury 158.5

source_name: Subject 22244667, hours since injury 158.5


title: Blood, subject 22244667, hours since injury 16.9

source_name: Subject 22244667, hours since injury 16.9


title: Patient 360; stage IA; AD

source_name: Patient 360


title: Patient 304; stage IB; AD

source_name: Patient 304


title: Patient 303; stage IB; Large

source_name: Patient 303

value: Large


title: Blood, subject 22244667, hours since injury 3.1

source_name: Subject 22244667, hours since injury 3.1


title: Blood, subject 21650192, hours since injury 178

source_name: Subject 21650192, hours since injury 178


title: Blood, subject 21650192, hours since injury 105.5

source_name: Subject 21650192, hours since injury 105.5


title: Blood, subject 21650192, hours since injury 346.2

source_name: Subject 21650192, hours since injury 346.2


title: Blood, subject 21650192, hours since injury 45.3

source_name: Subject 21650192, hours since injury 45.3


title: Blood, subject 22244667, hours since injury 87.8

source_name: Subject 22244667, hours since injury 87.8


title: Patient 278; stage IA; AD

source_name: Patient 278


title: Patient 280; stage IA; Poorly differentiated

source_name: Patient 280


title: Patient 277; stage IB; SCC

source_name: Patient 277


title: Blood, subject 21650192, hours since injury 10.9

source_name: Subject 21650192, hours since injury 10.9


title: Blood, subject 21615116, hours since injury 234.6

source_name: Subject 21615116, hours since injury 234.6


title: Blood, subject 21615116, hours since injury 113.9

source_name: Subject 21615116, hours since injury 113.9


title: Blood, subject 21413336, hours since injury 77.1

source_name: Subject 21413336, hours since injury 77.1


title: Blood, subject 21615116, hours since injury 11.8

source_name: Subject 21615116, hours since injury 11.8


title: Blood, subject 23853297, hours since injury 144.5

source_name: Subject 23853297, hours since injury 144.5


title: Blood, subject 21615116, hours since injury 35.7

source_name: Subject 21615116, hours since injury 35.7


title: Blood, subject 21413336, hours since injury 677.7

source_name: Subject 21413336, hours since injury 677.7


title: Patient 330; stage IA; SCC

source_name: Patient 330


title: Patient 334_2; stage IA; AD

source_name: Patient 334_2


title: Blood, subject 21413336, hours since injury 6.6

source_name: Subject 21413336, hours since injury 6.6


title: Patient 309_2; stage IB; Adenosquamous

source_name: Patient 309_2


title: Patient 300_2; stage IB; AD

source_name: Patient 300_2


title: Patient 275; stage IB; SCC

source_name: Patient 275


title: Patient 289_2; stage IB; Broncho-alveolar

source_name: Patient 289_2


title: Patient 408; stage IA; AD

source_name: Patient 408


title: Patient 263; stage IA; Neuroendocrine

source_name: Patient 263


title: Patient 276; stage IA; AD

source_name: Patient 276


title: Patient 262; stage IB; SCC

source_name: Patient 262


title: Patient 261; stage IB; SCC

source_name: Patient 261


title: Patient 407; stage IA; AD

source_name: Patient 407


title: Patient 139_2; stage IB; AD

source_name: Patient 139_2


title: Blood, subject 21413336, hours since injury 174.3

source_name: Subject 21413336, hours since injury 174.3


title: Patient 189; stage IB; SCC

source_name: Patient 189


title: Blood, subject 21413336, hours since injury 341.4

source_name: Subject 21413336, hours since injury 341.4


title: Blood, subject 21321531, hours since injury 333.3

source_name: Subject 21321531, hours since injury 333.3


title: Blood, subject 21321531, hours since injury 22.3

source_name: Subject 21321531, hours since injury 22.3


title: Blood, subject 21266782, hours since injury 33.8

source_name: Subject 21266782, hours since injury 33.8


title: Blood, subject 21321531, hours since injury 94.2

source_name: Subject 21321531, hours since injury 94.2


title: Blood, subject 21321531, hours since injury 166.2

source_name: Subject 21321531, hours since injury 166.2


title: Blood, subject 21321531, hours since injury 2.3

source_name: Subject 21321531, hours since injury 2.3


title: Blood, subject 21413336, hours since injury 42.3

source_name: Subject 21413336, hours since injury 42.3


title: Blood, subject 21266782, hours since injury 154.3

source_name: Subject 21266782, hours since injury 154.3


title: Blood, subject 21413336, hours since injury 512.5

source_name: Subject 21413336, hours since injury 512.5


title: Patient 264; stage IA; AD

source_name: Patient 264


title: Patient 282_2; stage IA; AD

source_name: Patient 282_2


title: Patient 316_2; stage IB; AD

source_name: Patient 316_2


title: Blood, subject 21266782, hours since injury 490.4

source_name: Subject 21266782, hours since injury 490.4


title: Blood, subject 21266782, hours since injury 105.7

source_name: Subject 21266782, hours since injury 105.7


title: Blood, subject 21266782, hours since injury 11.5

source_name: Subject 21266782, hours since injury 11.5


title: Patient 259; stage IA; SCC

source_name: Patient 259


title: Patient 242; stage IB; AD

source_name: Patient 242


title: Patient 260; stage IB; AD

source_name: Patient 260


title: Blood, subject 21098703, hours since injury 36.8

source_name: Subject 21098703, hours since injury 36.8


title: Patient 241; stage IB; SCC

source_name: Patient 241


title: Patient 186_2; stage IA; AD

source_name: Patient 186_2


title: Patient 240; stage IA; SCC

source_name: Patient 240


title: Patient 258; stage IB; SCC

source_name: Patient 258


title: Patient 239; stage IA; AD

source_name: Patient 239


title: Blood, subject 20340215, hours since injury 353.2

source_name: Subject 20340215, hours since injury 353.2


title: Blood, subject 20340215, hours since injury 12.6

source_name: Subject 20340215, hours since injury 12.6


title: Blood, subject 20340215, hours since injury 41.6

source_name: Subject 20340215, hours since injury 41.6


title: Blood, subject 20340215, hours since injury 185.1

source_name: Subject 20340215, hours since injury 185.1


title: Blood, subject 21098703, hours since injury 12.5

source_name: Subject 21098703, hours since injury 12.5


title: Blood, subject 20008375, hours since injury 63.3

source_name: Subject 20008375, hours since injury 63.3


title: Blood, subject 20008375, hours since injury 5.3

source_name: Subject 20008375, hours since injury 5.3


title: Patient 193_2; stage IA; AD

source_name: Patient 193_2


title: Patient 192_2; stage IB; Broncho-alveolar

source_name: Patient 192_2


title: Blood, subject 19735109, hours since injury 688

source_name: Subject 19735109, hours since injury 688


title: Patient 329_2; stage IB; SCC

source_name: Patient 329_2


title: Patient 328_2; stage IB; SCC

source_name: Patient 328_2


title: Patient 198_2; stage IB; SCC

source_name: Patient 198_2


title: Patient 238; stage IA; SCC

source_name: Patient 238


title: Blood, subject 19735109, hours since injury 520.2

source_name: Subject 19735109, hours since injury 520.2


title: Patient 237; stage IA; AD

source_name: Patient 237


title: Patient 236; stage IA; Poorly differentiated

source_name: Patient 236


title: Patient 201; stage IA; SCC

source_name: Patient 201


title: Patient 200; stage IB; AD

source_name: Patient 200


title: Blood, subject 20340215, hours since injury 112.9

source_name: Subject 20340215, hours since injury 112.9


title: Blood, subject 19735109, hours since injury 352.9

source_name: Subject 19735109, hours since injury 352.9


title: Blood, subject 19735109, hours since injury 43

source_name: Subject 19735109, hours since injury 43


title: Patient 222; stage IB; SCC

source_name: Patient 222


title: Patient 169; stage IB; SCC

source_name: Patient 169


title: Patient 324_2; stage IB; AD

source_name: Patient 324_2


title: Patient 318_2; stage IA; AD

source_name: Patient 318_2


title: Patient 314_2; stage IA; Large

source_name: Patient 314_2


title: Patient 321_2; stage IB; AD

source_name: Patient 321_2


title: Blood, subject 20008375, hours since injury 136.2

source_name: Subject 20008375, hours since injury 136.2


title: Blood, subject 19735109, hours since injury 110.5

source_name: Subject 19735109, hours since injury 110.5


title: Blood, subject 20008375, hours since injury 14.3

source_name: Subject 20008375, hours since injury 14.3


title: Blood, subject 19731218, hours since injury 343.3

source_name: Subject 19731218, hours since injury 343.3


title: Blood, subject 19735109, hours since injury 183.8

source_name: Subject 19735109, hours since injury 183.8


title: Blood, subject 19731218, hours since injury 11.6

source_name: Subject 19731218, hours since injury 11.6


title: Blood, subject 19731218, hours since injury 31.2

source_name: Subject 19731218, hours since injury 31.2


title: Blood, subject 19645406, hours since injury 157.3

source_name: Subject 19645406, hours since injury 157.3


title: Blood, subject 19645406, hours since injury 85.2

source_name: Subject 19645406, hours since injury 85.2


title: Blood, subject 19645406, hours since injury 2.8

source_name: Subject 19645406, hours since injury 2.8


title: Blood, subject 19645406, hours since injury 13

source_name: Subject 19645406, hours since injury 13


title: Blood, subject 18878883, hours since injury 9.8

source_name: Subject 18878883, hours since injury 9.8


title: Patient 221; stage IB; AD

source_name: Patient 221


title: Blood, subject 19735109, hours since injury 11.5

source_name: Subject 19735109, hours since injury 11.5


title: Blood, subject 19731218, hours since injury 129.7

source_name: Subject 19731218, hours since injury 129.7


title: Patient 271_2; stage IB; AD

source_name: Patient 271_2


title: Patient 220; stage IA; AD

source_name: Patient 220


title: Blood, subject 18878883, hours since injury 42.6

source_name: Subject 18878883, hours since injury 42.6


title: Patient 218; stage IA; AD

source_name: Patient 218


title: Blood, subject 18878883, hours since injury 689.3

source_name: Subject 18878883, hours since injury 689.3


title: Patient 219; stage IB; AD

source_name: Patient 219


title: Patient 217; stage IB; Adenosquamous

source_name: Patient 217


title: Blood, subject 18878883, hours since injury 185.3

source_name: Subject 18878883, hours since injury 185.3


title: Blood, subject 18878883, hours since injury 353.5

source_name: Subject 18878883, hours since injury 353.5


title: Blood, subject 18878883, hours since injury 137.9

source_name: Subject 18878883, hours since injury 137.9


title: Patient 123_2; stage IA; SCC

source_name: Patient 123_2


title: Patient 12_3; stage IB; AD

source_name: Patient 12_3


title: Patient 294_2; stage IB; AD

source_name: Patient 294_2


title: Blood, subject 18848800, hours since injury 500.8

source_name: Subject 18848800, hours since injury 500.8


title: Blood, subject 18848800, hours since injury 91.9

source_name: Subject 18848800, hours since injury 91.9


title: Patient 113_2; stage IA; AD

source_name: Patient 113_2


title: Patient 12_2; stage IB; AD

source_name: Patient 12_2


title: Patient 190; stage IB; AD

source_name: Patient 190


title: Blood, subject 18848800, hours since injury 669.1

source_name: Subject 18848800, hours since injury 669.1


title: Blood, subject 18848800, hours since injury 332.7

source_name: Subject 18848800, hours since injury 332.7


title: Patient 171; stage IB; SCC

source_name: Patient 171


title: Patient 172; stage IB; SCC

source_name: Patient 172


title: Patient 55_2; stage IB; AD

source_name: Patient 55_2


title: Blood, subject 18848800, hours since injury 25.7

source_name: Subject 18848800, hours since injury 25.7


title: Blood, subject 18814936, hours since injury 5.9

source_name: Subject 18814936, hours since injury 5.9


title: Blood, subject 18814936, hours since injury 63.2

source_name: Subject 18814936, hours since injury 63.2


title: Blood, subject 18814936, hours since injury 14.7

source_name: Subject 18814936, hours since injury 14.7


title: Blood, subject 18848800, hours since injury 2

source_name: Subject 18848800, hours since injury 2


title: Patient 120; stage IA; Poorly differentiated

source_name: Patient 120


title: Patient 193; stage IA; AD

source_name: Patient 193


title: Patient 281_2; stage IB; AD

source_name: Patient 281_2


title: Patient 192; stage IB; Broncho-alveolar

source_name: Patient 192


title: Patient 121; stage IA; AD

source_name: Patient 121


title: Patient 134; stage IA; AD

source_name: Patient 134


title: Blood, subject 18814936, hours since injury 135.2

source_name: Subject 18814936, hours since injury 135.2


title: Patient 29; stage IB; Poorly differentiated

source_name: Patient 29


title: Patient 334; stage IA; AD

source_name: Patient 334


title: Blood, subject 18791491, hours since injury 9.9

source_name: Subject 18791491, hours since injury 9.9


title: Patient 27; stage IB; SCC

source_name: Patient 27


title: Patient 357; stage IA; Poorly differentiated

source_name: Patient 357


title: Blood, subject 18791491, hours since injury 351.9

source_name: Subject 18791491, hours since injury 351.9


title: Blood, subject 18791491, hours since injury 177.2

source_name: Subject 18791491, hours since injury 177.2


title: Patient 176; stage IB; AD

source_name: Patient 176


title: Patient 355; stage IA; AD

source_name: Patient 355


title: Blood, subject 18761959, hours since injury 329.3

source_name: Subject 18761959, hours since injury 329.3


title: Blood, subject 18761959, hours since injury 8.9

source_name: Subject 18761959, hours since injury 8.9


title: Patient 352; stage IA; SCC

source_name: Patient 352


title: Patient 356; stage IA; Broncho-alveolar

source_name: Patient 356


title: Blood, subject 18791491, hours since injury 106.8

source_name: Subject 18791491, hours since injury 106.8


title: Patient 333; stage IB; Adenosquamous

source_name: Patient 333


title: Blood, subject 18791491, hours since injury 513.8

source_name: Subject 18791491, hours since injury 513.8


title: Patient 326; stage IB; Poorly differentiated

source_name: Patient 326


title: Patient 327; stage IB; AD

source_name: Patient 327


title: Blood, subject 18761959, hours since injury 65.7

source_name: Subject 18761959, hours since injury 65.7


title: Blood, subject 18761959, hours since injury 17.8

source_name: Subject 18761959, hours since injury 17.8


title: Blood, subject 18335215, hours since injury 35.1

source_name: Subject 18335215, hours since injury 35.1


title: Blood, subject 18359204, hours since injury 12.1

source_name: Subject 18359204, hours since injury 12.1


title: Blood, subject 18359204, hours since injury 31.7

source_name: Subject 18359204, hours since injury 31.7


title: Patient 325; stage IB; AD

source_name: Patient 325


title: Patient 354; stage IA; AD

source_name: Patient 354


title: Blood, subject 18335215, hours since injury 11.1

source_name: Subject 18335215, hours since injury 11.1


title: Blood, subject 18761959, hours since injury 160.8

source_name: Subject 18761959, hours since injury 160.8


title: Blood, subject 18848800, hours since injury 167.3

source_name: Subject 18848800, hours since injury 167.3


title: Blood, subject 18320652, hours since injury 39

source_name: Subject 18320652, hours since injury 39


title: Patient 418; stage IA; SCC

source_name: Patient 418


title: Patient 293; stage IB; AD

source_name: Patient 293


title: Patient 417; stage IA; AD

source_name: Patient 417


title: Patient 292; stage IA; SCC

source_name: Patient 292


title: Patient 274; stage IA; SCC

source_name: Patient 274


title: Patient 323; stage IA; AD

source_name: Patient 323


title: Patient 272; stage IA; AD

source_name: Patient 272


title: Blood, subject 18335215, hours since injury 108.4

source_name: Subject 18335215, hours since injury 108.4


title: Patient 257; stage IB; AD

source_name: Patient 257


title: Patient 321; stage IB; AD

source_name: Patient 321


title: Patient 322; stage IB; SCC

source_name: Patient 322


title: Blood, subject 18320652, hours since injury 181.5

source_name: Subject 18320652, hours since injury 181.5


title: Blood, subject 18172677, hours since injury 38.7

source_name: Subject 18172677, hours since injury 38.7


title: Blood, subject 18320652, hours since injury 111.1

source_name: Subject 18320652, hours since injury 111.1


title: Blood, subject 18320652, hours since injury 11.7

source_name: Subject 18320652, hours since injury 11.7


title: Patient 273; stage IA; SCC

source_name: Patient 273


title: Blood, subject 18172677, hours since injury 181.1

source_name: Subject 18172677, hours since injury 181.1


title: Blood, subject 18172677, hours since injury 108.4

source_name: Subject 18172677, hours since injury 108.4


title: Blood, subject 18172677, hours since injury 11.5

source_name: Subject 18172677, hours since injury 11.5


title: Patient 320; stage IA; AD

source_name: Patient 320


title: Blood, subject 18172677, hours since injury 347.8

source_name: Subject 18172677, hours since injury 347.8


title: Blood, subject 18172677, hours since injury 515.7

source_name: Subject 18172677, hours since injury 515.7


title: Blood, subject 17992882, hours since injury 103.5

source_name: Subject 17992882, hours since injury 103.5


title: Patient 324; stage IB; AD

source_name: Patient 324


title: Patient 256; stage IA; AD

source_name: Patient 256


title: Blood, subject 179495, hours since injury 89

source_name: Subject 179495, hours since injury 89


title: Blood, subject 179495, hours since injury 329

source_name: Subject 179495, hours since injury 329


title: Blood, subject 179495, hours since injury 5.5

source_name: Subject 179495, hours since injury 5.5


title: Blood, subject 17992882, hours since injury 8

source_name: Subject 17992882, hours since injury 8


title: Blood, subject 17992882, hours since injury 31.6

source_name: Subject 17992882, hours since injury 31.6


title: Patient 298; stage IA; SCC

source_name: Patient 298


title: Patient 255; stage IB; AD

source_name: Patient 255


title: Patient 254; stage IB; AD

source_name: Patient 254


title: Patient 309; stage IB; Adenosquamous

source_name: Patient 309


title: Patient 307; stage IB; AD

source_name: Patient 307


title: Patient 405; stage IA; AD

source_name: Patient 405


title: Patient 301; stage IB; AD

source_name: Patient 301


title: Blood, subject 179495, hours since injury 24

source_name: Subject 179495, hours since injury 24


title: Patient 302; stage IB; SCC

source_name: Patient 302


title: Patient 300; stage IB; AD

source_name: Patient 300


title: Patient 253; stage IA; AD

source_name: Patient 253


title: Patient 235; stage IB; AD

source_name: Patient 235


title: Blood, subject 179495, hours since injury 137.5

source_name: Subject 179495, hours since injury 137.5


title: Blood, subject 17889263, hours since injury 373.9

source_name: Subject 17889263, hours since injury 373.9


title: Blood, subject 17889263, hours since injury 106.5

source_name: Subject 17889263, hours since injury 106.5


title: Blood, subject 17747412, hours since injury 24.6

source_name: Subject 17747412, hours since injury 24.6


title: Blood, subject 17889263, hours since injury 538.7

source_name: Subject 17889263, hours since injury 538.7


title: Patient 232; stage IA; AD

source_name: Patient 232


title: Patient 231; stage IA; AD

source_name: Patient 231


title: Patient 230; stage IB; AD

source_name: Patient 230


title: Blood, subject 17747412, hours since injury 341.4

source_name: Subject 17747412, hours since injury 341.4


title: Blood, subject 17873227, hours since injury 9.5

source_name: Subject 17873227, hours since injury 9.5


title: Patient 234; stage IB; SCC

source_name: Patient 234


title: Blood, subject 17889263, hours since injury 12.5

source_name: Subject 17889263, hours since injury 12.5


title: Blood, subject 17889263, hours since injury 38.9

source_name: Subject 17889263, hours since injury 38.9


title: Blood, subject 17747412, hours since injury 99.5

source_name: Subject 17747412, hours since injury 99.5


title: Blood, subject 17686459, hours since injury 8.3

source_name: Subject 17686459, hours since injury 8.3


title: Blood, subject 17747412, hours since injury 1.7

source_name: Subject 17747412, hours since injury 1.7


title: Patient 233; stage IB; SCC

source_name: Patient 233


title: Patient 229; stage IA; Broncho-alveolar

source_name: Patient 229


title: Patient 404; stage IB; AD

source_name: Patient 404


title: Patient 297; stage IB; SCC

source_name: Patient 297


title: Patient 59_2; stage IB; AD

source_name: Patient 59_2


title: Patient 212; stage IA; SCC

source_name: Patient 212


title: Blood, subject 17873227, hours since injury 27.6

source_name: Subject 17873227, hours since injury 27.6


title: Patient 54; stage IB; AD

source_name: Patient 54


title: Blood, subject 17686459, hours since injury 198.5

source_name: Subject 17686459, hours since injury 198.5


title: Patient 211; stage IA; AD

source_name: Patient 211


title: Patient 216; stage IB; AD

source_name: Patient 216


title: Patient 228; stage IA; AD

source_name: Patient 228


title: Patient 55; stage IB; AD

source_name: Patient 55


title: Patient 214; stage IA; AD

source_name: Patient 214


title: Blood, subject 17686459, hours since injury 366.2

source_name: Subject 17686459, hours since injury 366.2


title: Patient 213; stage IA; SCC

source_name: Patient 213


title: Patient 53_2; stage IB; AD

source_name: Patient 53_2


title: Blood, subject 17686459, hours since injury 558.8

source_name: Subject 17686459, hours since injury 558.8


title: Blood, subject 17596176, hours since injury 369.2

source_name: Subject 17596176, hours since injury 369.2


title: Blood, subject 17686459, hours since injury 102

source_name: Subject 17686459, hours since injury 102


title: Blood, subject 17686459, hours since injury 29.5

source_name: Subject 17686459, hours since injury 29.5


title: Blood, subject 17596176, hours since injury 33

source_name: Subject 17596176, hours since injury 33


title: Blood, subject 17596176, hours since injury 110

source_name: Subject 17596176, hours since injury 110


title: Blood, subject 17596176, hours since injury 8.8

source_name: Subject 17596176, hours since injury 8.8


title: Blood, subject 17596176, hours since injury 226

source_name: Subject 17596176, hours since injury 226


title: Patient 363; stage IA; SCC

source_name: Patient 363


title: Blood, subject 17225408, hours since injury 99.4

source_name: Subject 17225408, hours since injury 99.4


title: Blood, subject 17225408, hours since injury 8.8

source_name: Subject 17225408, hours since injury 8.8


title: Blood, subject 17225408, hours since injury 361.9

source_name: Subject 17225408, hours since injury 361.9


title: Blood, subject 17225408, hours since injury 507.6

source_name: Subject 17225408, hours since injury 507.6


title: Blood, subject 17889263, hours since injury 206.8

source_name: Subject 17889263, hours since injury 206.8


title: Patient 48_2; stage IB; SCC

source_name: Patient 48_2


title: Blood, subject 17225408, hours since injury 697.2

source_name: Subject 17225408, hours since injury 697.2


title: Patient 284; stage IB; AD

source_name: Patient 284


title: Patient 186; stage IA; AD

source_name: Patient 186


title: Patient 279; stage IB; AD

source_name: Patient 279


title: Patient 160; stage IB; Neuroendocrine

source_name: Patient 160


title: Patient 158; stage IA; AD

source_name: Patient 158


title: Patient 156; stage IB; Adenosquamous

source_name: Patient 156


title: Patient 155; stage IA; SCC

source_name: Patient 155


title: Patient 174; stage IA; Broncho-alveolar

source_name: Patient 174


title: Blood, subject 17225408, hours since injury 26.3

source_name: Subject 17225408, hours since injury 26.3


title: Patient 185; stage IB; Broncho-alveolar

source_name: Patient 185


title: Patient 188; stage IB; SCC

source_name: Patient 188


title: Blood, subject 17207778, hours since injury 380.3

source_name: Subject 17207778, hours since injury 380.3


title: Patient 179; stage IB; SCC

source_name: Patient 179


title: Patient 184_2; stage IA; AD

source_name: Patient 184_2


title: Blood, subject 17225408, hours since injury 195.5

source_name: Subject 17225408, hours since injury 195.5


title: Blood, subject 17207778, hours since injury 188.2

source_name: Subject 17207778, hours since injury 188.2


title: Blood, subject 16832704, hours since injury 92.5

source_name: Subject 16832704, hours since injury 92.5


title: Blood, subject 16832704, hours since injury 163.6

source_name: Subject 16832704, hours since injury 163.6


title: Blood, subject 17207778, hours since injury 39.6

source_name: Subject 17207778, hours since injury 39.6


title: Blood, subject 17207778, hours since injury 139.9

source_name: Subject 17207778, hours since injury 139.9


title: Blood, subject 17207778, hours since injury 11.3

source_name: Subject 17207778, hours since injury 11.3


title: Blood, subject 16832704, hours since injury 21

source_name: Subject 16832704, hours since injury 21


title: Blood, subject 16622938, hours since injury 35.3

source_name: Subject 16622938, hours since injury 35.3


title: Blood, subject 16622938, hours since injury 323.3

source_name: Subject 16622938, hours since injury 323.3


title: Patient 173; stage IB; SCC

source_name: Patient 173


title: Patient 151; stage IA; AD

source_name: Patient 151


title: Blood, subject 16622938, hours since injury 107.3

source_name: Subject 16622938, hours since injury 107.3


title: Blood, subject 16622938, hours since injury 156.3

source_name: Subject 16622938, hours since injury 156.3


title: Patient 150; stage IB; Poorly differentiated

source_name: Patient 150


title: Patient 149; stage IA; AD

source_name: Patient 149


title: Blood, subject 16622938, hours since injury 10.7

source_name: Subject 16622938, hours since injury 10.7


title: Blood, subject 16519431, hours since injury 9.3

source_name: Subject 16519431, hours since injury 9.3


title: Blood, subject 16519431, hours since injury 34

source_name: Subject 16519431, hours since injury 34


title: Patient 119; stage IA; Broncho-alveolar

source_name: Patient 119


title: Patient 123; stage IA; SCC

source_name: Patient 123


title: Patient 122; stage IA; AD

source_name: Patient 122


title: Patient 170; stage IA; AD

source_name: Patient 170


title: Blood, subject 16519431, hours since injury 180.2

source_name: Subject 16519431, hours since injury 180.2


title: Blood, subject 16515711, hours since injury 32.7

source_name: Subject 16515711, hours since injury 32.7


title: Blood, subject 16519431, hours since injury 111.8

source_name: Subject 16519431, hours since injury 111.8


title: Blood, subject 16515711, hours since injury 176.8

source_name: Subject 16515711, hours since injury 176.8


title: Blood, subject 16515711, hours since injury 104.8

source_name: Subject 16515711, hours since injury 104.8


title: Patient 133; stage IA; AD

source_name: Patient 133


title: Patient 117; stage IA; AD

source_name: Patient 117


title: Patient 182; stage IB; AD

source_name: Patient 182


title: Blood, subject 16515711, hours since injury 10.5

source_name: Subject 16515711, hours since injury 10.5


title: Patient 132; stage IA; SCC

source_name: Patient 132


title: Patient 114; stage IA; AD

source_name: Patient 114


title: Patient 139; stage IB; AD

source_name: Patient 139


title: Blood, subject 16832704, hours since injury 9.3

source_name: Subject 16832704, hours since injury 9.3


title: Patient 157; stage IB; SCC

source_name: Patient 157


title: Blood, subject 1614058, hours since injury 91.7

source_name: Subject 1614058, hours since injury 91.7


title: Blood, subject 1614058, hours since injury 3.6

source_name: Subject 1614058, hours since injury 3.6


title: Patient 146; stage IA; SCC

source_name: Patient 146


title: Blood, subject 1614058, hours since injury 163.3

source_name: Subject 1614058, hours since injury 163.3


title: Blood, subject 1614058, hours since injury 19.6

source_name: Subject 1614058, hours since injury 19.6


title: Blood, subject 16435097, hours since injury 22.7

source_name: Subject 16435097, hours since injury 22.7


title: Patient 161; stage IA; Broncho-alveolar

source_name: Patient 161


title: Patient 203; stage IA; SCC

source_name: Patient 203


title: Patient 115; stage IA; AD

source_name: Patient 115


title: Patient 313_2; stage IB; SCC

source_name: Patient 313_2


title: Blood, subject 15946469, hours since injury 8.8

source_name: Subject 15946469, hours since injury 8.8


title: Blood, subject 16435097, hours since injury 2

source_name: Subject 16435097, hours since injury 2


title: Patient 184; stage IA; AD

source_name: Patient 184


title: Patient 345; stage IA; SCC

source_name: Patient 345


title: Patient 295_2; stage IB; AD

source_name: Patient 295_2


title: Blood, subject 1614058, hours since injury 331.3

source_name: Subject 1614058, hours since injury 331.3


title: Patient 145; stage IA; SCC

source_name: Patient 145


title: Blood, subject 15946469, hours since injury 488

source_name: Subject 15946469, hours since injury 488


title: Patient 148; stage IA; Adenosquamous

source_name: Patient 148


title: Patient 20; stage IB; SCC

source_name: Patient 20


title: Patient 412; stage IB; SCC

source_name: Patient 412


title: Patient 406; stage IB; Broncho-alveolar

source_name: Patient 406


title: Patient 411; stage IA; AD

source_name: Patient 411


title: Patient 350; stage IA; AD

source_name: Patient 350


title: Patient 59; stage IB; AD

source_name: Patient 59


title: Blood, subject 15629307, hours since injury 5.3

source_name: Subject 15629307, hours since injury 5.3


title: Blood, subject 15946469, hours since injury 32.6

source_name: Subject 15946469, hours since injury 32.6


title: Blood, subject 15946469, hours since injury 344.3

source_name: Subject 15946469, hours since injury 344.3


title: Blood, subject 15629307, hours since injury 27.3

source_name: Subject 15629307, hours since injury 27.3


title: Blood, subject 15946469, hours since injury 103.3

source_name: Subject 15946469, hours since injury 103.3


title: Blood, subject 15429976, hours since injury 88.2

source_name: Subject 15429976, hours since injury 88.2


title: Blood, subject 15429976, hours since injury 663.8

source_name: Subject 15429976, hours since injury 663.8


title: Patient 331; stage IB; SCC

source_name: Patient 331


title: Patient 349; stage IA; Neuroendocrine

source_name: Patient 349


title: Blood, subject 15429976, hours since injury 496.9

source_name: Subject 15429976, hours since injury 496.9


title: Patient 53; stage IB; AD

source_name: Patient 53


title: Blood, subject 15287836, hours since injury 5.9

source_name: Subject 15287836, hours since injury 5.9


title: Blood, subject 15429976, hours since injury 5.8

source_name: Subject 15429976, hours since injury 5.8


title: Patient 48; stage IB; SCC

source_name: Patient 48


title: Patient 199; stage IB; AD

source_name: Patient 199


title: Blood, subject 15287836, hours since injury 710.2

source_name: Subject 15287836, hours since injury 710.2


title: Blood, subject 15429976, hours since injury 330.1

source_name: Subject 15429976, hours since injury 330.1


title: Patient 338_2; stage IA; SCC

source_name: Patient 338_2


title: Patient 343; stage IA; AD

source_name: Patient 343


title: Patient 23; stage IB; Broncho-alveolar

source_name: Patient 23


title: Patient 347; stage IA; SCC

source_name: Patient 347


title: Patient 21; stage IB; AD

source_name: Patient 21


title: Patient 348; stage IA; Poorly differentiated

source_name: Patient 348


title: Patient 346; stage IA; AD

source_name: Patient 346


title: Patient 402; stage IA; SCC

source_name: Patient 402


title: Patient 344; stage IA; SCC

source_name: Patient 344


title: Patient 308; stage IA; AD

source_name: Patient 308


title: Patient 290; stage IB; SCC

source_name: Patient 290


title: Blood, subject 15287836, hours since injury 370.8

source_name: Subject 15287836, hours since injury 370.8


title: Blood, subject 15287836, hours since injury 103.7

source_name: Subject 15287836, hours since injury 103.7


title: Blood, subject 14922137, hours since injury 96.8

source_name: Subject 14922137, hours since injury 96.8


title: Blood, subject 14922137, hours since injury 25

source_name: Subject 14922137, hours since injury 25


title: Blood, subject 14922137, hours since injury 168.3

source_name: Subject 14922137, hours since injury 168.3


title: Blood, subject 15429976, hours since injury 161.8

source_name: Subject 15429976, hours since injury 161.8


title: Blood, subject 14922137, hours since injury 335.8

source_name: Subject 14922137, hours since injury 335.8


title: Blood, subject 14761493, hours since injury 666.8

source_name: Subject 14761493, hours since injury 666.8


title: Patient 287; stage IA; AD

source_name: Patient 287


title: Blood, subject 15287836, hours since injury 178.6

source_name: Subject 15287836, hours since injury 178.6


title: Blood, subject 14922137, hours since injury 6.2

source_name: Subject 14922137, hours since injury 6.2


title: Patient 286; stage IB; Adenosquamous

source_name: Patient 286


title: Blood, subject 14761493, hours since injury 95

source_name: Subject 14761493, hours since injury 95


title: Blood, subject 14761493, hours since injury 19.4

source_name: Subject 14761493, hours since injury 19.4


title: Blood, subject 14761493, hours since injury 500.3

source_name: Subject 14761493, hours since injury 500.3


title: Blood, subject 15946469, hours since injury 175.2

source_name: Subject 15946469, hours since injury 175.2


title: Patient 285; stage IA; SCC

source_name: Patient 285


title: Blood, subject 15287836, hours since injury 538.5

source_name: Subject 15287836, hours since injury 538.5


title: Patient 196; stage IA; AD

source_name: Patient 196


title: Patient 269; stage IB; AD

source_name: Patient 269


title: Blood, subject 14761493, hours since injury 332.1

source_name: Subject 14761493, hours since injury 332.1


title: Patient 198; stage IB; SCC

source_name: Patient 198


title: Patient 342; stage IA; Neuroendocrine

source_name: Patient 342


title: Patient 340; stage IB; SCC

source_name: Patient 340


title: Blood, subject 14761493, hours since injury 162.2

source_name: Subject 14761493, hours since injury 162.2


title: Patient 338; stage IA; SCC

source_name: Patient 338


title: Patient 329; stage IB; SCC

source_name: Patient 329


title: Patient 318; stage IA; AD

source_name: Patient 318


title: Patient 328; stage IB; SCC

source_name: Patient 328


title: Blood, subject 14761493, hours since injury 1.4

source_name: Subject 14761493, hours since injury 1.4


title: Patient 267; stage IA; AD

source_name: Patient 267


title: Patient 268; stage IA; SCC

source_name: Patient 268


title: Patient 248; stage IA; SCC

source_name: Patient 248


title: Blood, subject 14484685, hours since injury 95.2

source_name: Subject 14484685, hours since injury 95.2


title: Patient 317; stage IA; SCC

source_name: Patient 317


title: Blood, subject 14568998, hours since injury 73.9

source_name: Subject 14568998, hours since injury 73.9


title: Patient 353; stage IA; AD

source_name: Patient 353


title: Blood, subject 14484685, hours since injury 503

source_name: Subject 14484685, hours since injury 503


title: Blood, subject 14484685, hours since injury 166.6

source_name: Subject 14484685, hours since injury 166.6


title: Blood, subject 14484685, hours since injury 12.2

source_name: Subject 14484685, hours since injury 12.2


title: Blood, subject 14568998, hours since injury 1.7

source_name: Subject 14568998, hours since injury 1.7


title: Blood, subject 14568998, hours since injury 25.5

source_name: Subject 14568998, hours since injury 25.5


title: Blood, subject 14356349, hours since injury 33.2

source_name: Subject 14356349, hours since injury 33.2


title: Blood, subject 14484685, hours since injury 30.4

source_name: Subject 14484685, hours since injury 30.4


title: Blood, subject 14568998, hours since injury 172.3

source_name: Subject 14568998, hours since injury 172.3


title: Blood, subject 14356349, hours since injury 11.3

source_name: Subject 14356349, hours since injury 11.3


title: Blood, subject 14356349, hours since injury 106.7

source_name: Subject 14356349, hours since injury 106.7


title: Patient 266; stage IB; AD

source_name: Patient 266


title: Blood, subject 14298862, hours since injury 48

source_name: Subject 14298862, hours since injury 48


title: Patient 246; stage IB; SCC

source_name: Patient 246


title: Patient 247; stage IB; Large

source_name: Patient 247


title: Patient 206; stage IB; AD

source_name: Patient 206


title: Blood, subject 14298862, hours since injury 112.1

source_name: Subject 14298862, hours since injury 112.1


title: Patient 225; stage IB; AD

source_name: Patient 225


title: Blood, subject 14298862, hours since injury 12

source_name: Subject 14298862, hours since injury 12


title: Patient 226; stage IB; AD

source_name: Patient 226


title: Patient 224; stage IB; SCC

source_name: Patient 224


title: Blood, subject 1368657, hours since injury 683.1

source_name: Subject 1368657, hours since injury 683.1


title: Blood, subject 1368657, hours since injury 516.3

source_name: Subject 1368657, hours since injury 516.3


title: Patient 207; stage IB; Poorly differentiated

source_name: Patient 207


title: Patient 249; stage IB; AD

source_name: Patient 249


title: Patient 316; stage IB; AD

source_name: Patient 316


title: Patient 314; stage IA; Large

source_name: Patient 314


title: Blood, subject 1368657, hours since injury 5.2

source_name: Subject 1368657, hours since injury 5.2


title: Patient 313; stage IB; SCC

source_name: Patient 313


title: Blood, subject 1368657, hours since injury 105.6

source_name: Subject 1368657, hours since injury 105.6


title: Blood, subject 1352072, hours since injury 682.5

source_name: Subject 1352072, hours since injury 682.5


title: Blood, subject 1368657, hours since injury 32.8

source_name: Subject 1368657, hours since injury 32.8


title: Blood, subject 1368657, hours since injury 201.3

source_name: Subject 1368657, hours since injury 201.3


title: Blood, subject 1352072, hours since injury 178.8

source_name: Subject 1352072, hours since injury 178.8


title: Patient 312; stage IB; Adenosquamous

source_name: Patient 312


title: Patient 162; stage IA; AD

source_name: Patient 162


title: Patient 137; stage IA; AD

source_name: Patient 137


title: Patient 315; stage IB; AD

source_name: Patient 315


title: Patient 288; stage IB; SCC

source_name: Patient 288


title: Patient 289; stage IB; Broncho-alveolar

source_name: Patient 289


title: Patient 294; stage IB; AD

source_name: Patient 294


title: Patient 295; stage IB; AD

source_name: Patient 295


title: Blood, subject 1352072, hours since injury 347.5

source_name: Subject 1352072, hours since injury 347.5


title: Blood, subject 1352072, hours since injury 10.6

source_name: Subject 1352072, hours since injury 10.6


title: Blood, subject 13323384, hours since injury 674.3

source_name: Subject 13323384, hours since injury 674.3


title: Blood, subject 1352072, hours since injury 35

source_name: Subject 1352072, hours since injury 35


title: Blood, subject 13323384, hours since injury 504.8

source_name: Subject 13323384, hours since injury 504.8


title: Blood, subject 13289348, hours since injury 33

source_name: Subject 13289348, hours since injury 33


title: Blood, subject 13289348, hours since injury 9.7

source_name: Subject 13289348, hours since injury 9.7


title: Blood, subject 13323384, hours since injury 337.5

source_name: Subject 13323384, hours since injury 337.5


title: Blood, subject 1352072, hours since injury 106.5

source_name: Subject 1352072, hours since injury 106.5


title: Patient 306; stage IA; SCC

source_name: Patient 306


title: Patient 204; stage IA; AD

source_name: Patient 204


title: Patient 205; stage IA; SCC

source_name: Patient 205


title: Patient 250; stage IB; SCC

source_name: Patient 250


title: Patient 187; stage IB; AD

source_name: Patient 187


title: Blood, subject 13289348, hours since injury 200.5

source_name: Subject 13289348, hours since injury 200.5


title: Blood, subject 13289348, hours since injury 103.5

source_name: Subject 13289348, hours since injury 103.5


title: Blood, subject 13230417, hours since injury 9.6

source_name: Subject 13230417, hours since injury 9.6


title: Blood, subject 13230417, hours since injury 317.8

source_name: Subject 13230417, hours since injury 317.8


title: Blood, subject 13323384, hours since injury 5.8

source_name: Subject 13323384, hours since injury 5.8


title: Patient 128; stage IA; Broncho-alveolar

source_name: Patient 128


title: Blood, subject 15429976, hours since injury 16.9

source_name: Subject 15429976, hours since injury 16.9


title: Patient 140; stage IA; AD

source_name: Patient 140


title: Patient 138; stage IB; AD

source_name: Patient 138


title: Blood, subject 13230417, hours since injury 149.8

source_name: Subject 13230417, hours since injury 149.8


title: Patient 129; stage IA; AD

source_name: Patient 129


title: Patient 131; stage IA; AD

source_name: Patient 131


title: Patient 127; stage IB; SCC

source_name: Patient 127


title: Patient 5; stage IB; AD

source_name: Patient 5


title: Patient 46; stage IB; SCC

source_name: Patient 46


title: Blood, subject 12801380, hours since injury 38

source_name: Subject 12801380, hours since injury 38


title: Patient 16; stage IA; AD

source_name: Patient 16


title: Patient 283; stage IB; AD

source_name: Patient 283


title: Patient 104; stage IA; AD

source_name: Patient 104


title: Patient 12; stage IB; AD

source_name: Patient 12


title: Blood, subject 12801380, hours since injury 12

source_name: Subject 12801380, hours since injury 12


title: Blood, subject 1368657, hours since injury 344.6

source_name: Subject 1368657, hours since injury 344.6


title: Blood, subject 12801380, hours since injury 111

source_name: Subject 12801380, hours since injury 111


title: Blood, subject 1274923, hours since injury 181.9

source_name: Subject 1274923, hours since injury 181.9


title: Patient 282; stage IA; AD

source_name: Patient 282


title: Blood, subject 12801380, hours since injury 182.3

source_name: Subject 12801380, hours since injury 182.3


title: Blood, subject 12600235, hours since injury 99

source_name: Subject 12600235, hours since injury 99


title: Patient 168; stage IA; SCC

source_name: Patient 168


title: Patient 118; stage IB; AD

source_name: Patient 118


title: Blood, subject 12600235, hours since injury 507.3

source_name: Subject 12600235, hours since injury 507.3


title: Blood, subject 12600235, hours since injury 7.9

source_name: Subject 12600235, hours since injury 7.9


title: Blood, subject 1274923, hours since injury 38.9

source_name: Subject 1274923, hours since injury 38.9


title: Blood, subject 12801380, hours since injury 351.5

source_name: Subject 12801380, hours since injury 351.5


title: Blood, subject 1274923, hours since injury 86.3

source_name: Subject 1274923, hours since injury 86.3


title: Blood, subject 12600235, hours since injury 339.2

source_name: Subject 12600235, hours since injury 339.2


title: Blood, subject 12600235, hours since injury 27

source_name: Subject 12600235, hours since injury 27


title: Blood, subject 12600235, hours since injury 171

source_name: Subject 12600235, hours since injury 171


title: Blood, subject 1274923, hours since injury 12.7

source_name: Subject 1274923, hours since injury 12.7


title: Patient 110; stage IA; Poorly differentiated

source_name: Patient 110


title: Patient 153; stage IB; AD

source_name: Patient 153


title: Patient 183; stage IA; AD

source_name: Patient 183


title: Patient 113; stage IA; AD

source_name: Patient 113


title: Blood, subject 12597463, hours since injury 31.8

source_name: Subject 12597463, hours since injury 31.8


title: Patient 106; stage IA; AD

source_name: Patient 106


title: Patient 103; stage IA; AD

source_name: Patient 103


title: Blood, subject 12597463, hours since injury 4.4

source_name: Subject 12597463, hours since injury 4.4


title: Patient 310; stage IB; AD

source_name: Patient 310


title: Patient 109; stage IA; SCC

source_name: Patient 109


title: Patient 111; stage IA; Broncho-alveolar

source_name: Patient 111


title: Blood, subject 11541392, hours since injury 683.5

source_name: Subject 11541392, hours since injury 683.5


title: Patient 392; stage IA; AD

source_name: Patient 392


title: Patient 265; stage IB; SCC

source_name: Patient 265


title: Blood, subject 11541392, hours since injury 37.3

source_name: Subject 11541392, hours since injury 37.3


title: Patient 382; stage IA; AD

source_name: Patient 382


title: Patient 381; stage IA; AD

source_name: Patient 381


title: Blood, subject 11541392, hours since injury 517.5

source_name: Subject 11541392, hours since injury 517.5


title: Patient 70816-b; stage IA; SCC

source_name: Patient 70816-b


title: Blood, subject 11191616, hours since injury 693.8

source_name: Subject 11191616, hours since injury 693.8


title: Blood, subject 11541392, hours since injury 11.1

source_name: Subject 11541392, hours since injury 11.1


title: Blood, subject 11191616, hours since injury 333.5

source_name: Subject 11191616, hours since injury 333.5


title: Blood, subject 11191616, hours since injury 502.5

source_name: Subject 11191616, hours since injury 502.5


title: Blood, subject 11541392, hours since injury 347.5

source_name: Subject 11541392, hours since injury 347.5


title: Blood, subject 11191616, hours since injury 3.7

source_name: Subject 11191616, hours since injury 3.7


title: Blood, subject 13230417, hours since injury 487.7

source_name: Subject 13230417, hours since injury 487.7


title: Blood, subject 11541392, hours since injury 180.8

source_name: Subject 11541392, hours since injury 180.8


title: Blood, subject 11191616, hours since injury 165.9

source_name: Subject 11191616, hours since injury 165.9


title: Blood, subject 11541392, hours since injury 134.4

source_name: Subject 11541392, hours since injury 134.4


title: Patient 397; stage IA; AD

source_name: Patient 397


title: Patient 71037; stage IB; AD

source_name: Patient 71037


title: Patient 422; stage IA; AD

source_name: Patient 422


title: Patient 341; stage IB; Poorly differentiated

source_name: Patient 341


title: Patient 339; stage IA; AD

source_name: Patient 339


title: Patient 243; stage IB; SCC

source_name: Patient 243


title: Patient 53804-b; stage IB; Broncho-alveolar

source_name: Patient 53804-b


title: Patient 384; stage IA; Adenosquamous

source_name: Patient 384


title: Patient 414; stage IB; AD

source_name: Patient 414


title: Blood, subject 11040567, hours since injury 44.8

source_name: Subject 11040567, hours since injury 44.8


title: Blood, subject 11040567, hours since injury 102.5

source_name: Subject 11040567, hours since injury 102.5


title: Patient 70903; stage IB; AD

source_name: Patient 70903


title: Blood, subject 11040567, hours since injury 485.9

source_name: Subject 11040567, hours since injury 485.9


title: Patient 56319; stage IB; SCC

source_name: Patient 56319


title: Patient 396; stage IB; AD

source_name: Patient 396


title: Patient 391; stage IA; SCC

source_name: Patient 391


title: Blood, subject 1103804, hours since injury 40.4

source_name: Subject 1103804, hours since injury 40.4


title: Blood, subject 11040567, hours since injury 150.9

source_name: Subject 11040567, hours since injury 150.9


title: Blood, subject 1103804, hours since injury 520.2

source_name: Subject 1103804, hours since injury 520.2


title: Patient 380; stage IA; SCC

source_name: Patient 380


title: Blood, subject 11191616, hours since injury 117

source_name: Subject 11191616, hours since injury 117


title: Blood, subject 11040567, hours since injury 11.7

source_name: Subject 11040567, hours since injury 11.7


title: Blood, subject 11040567, hours since injury 654.9

source_name: Subject 11040567, hours since injury 654.9


title: Blood, subject 1103804, hours since injury 351.5

source_name: Subject 1103804, hours since injury 351.5


title: Blood, subject 11040567, hours since injury 318.8

source_name: Subject 11040567, hours since injury 318.8


title: Blood, subject 1103804, hours since injury 687.6

source_name: Subject 1103804, hours since injury 687.6


title: Patient 70870; stage IB; SCC

source_name: Patient 70870


title: Patient 71028; stage IA; SCC

source_name: Patient 71028


title: Blood, subject 1103804, hours since injury 183.8

source_name: Subject 1103804, hours since injury 183.8


title: Patient 53956; stage IB; AD

source_name: Patient 53956


title: Patient 390; stage IB; AD

source_name: Patient 390


title: Patient 385; stage IA; SCC

source_name: Patient 385


title: Patient 223; stage IA; Broncho-alveolar

source_name: Patient 223


title: Patient 165; stage IA; AD

source_name: Patient 165


title: Patient 410; stage IA; SCC

source_name: Patient 410


title: Blood, subject 10897903, hours since injury 2.3

source_name: Subject 10897903, hours since injury 2.3


title: Patient 378; stage IA; AD

source_name: Patient 378


title: Blood, subject 10897903, hours since injury 339

source_name: Subject 10897903, hours since injury 339


title: Blood, subject 1103804, hours since injury 12.7

source_name: Subject 1103804, hours since injury 12.7


title: Patient 296-b; stage IA; Broncho-alveolar

source_name: Patient 296-b


title: Patient 164; stage IA; AD

source_name: Patient 164


title: Blood, subject 10897903, hours since injury 125.3

source_name: Subject 10897903, hours since injury 125.3


title: Blood, subject 10821928, hours since injury 5.4

source_name: Subject 10821928, hours since injury 5.4


title: Patient 395; stage IA; AD

source_name: Patient 395


title: Blood, subject 10821928, hours since injury 87.6

source_name: Subject 10821928, hours since injury 87.6


title: Blood, subject 10897903, hours since injury 25.4

source_name: Subject 10897903, hours since injury 25.4


title: Patient 337; stage IB; AD

source_name: Patient 337


title: siMM_D10_B

city: Birmingham

first: Salam

middle: Adli

last: Assi

address: IBR

department: Institute for Cancer and Genomic Sciences

country: United Kingdom

institute: University of Birmingham

description: 72 h after 3rd electroporation

hyb_protocol: Standard Illumina hybridization protocol

data_processing: The data were normalised using quantile normalisation with Lumi R package

label: Biotin

source_name: RUNX1/ETO mismatch control 240h

label_protocol: Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays

growth_protocol: Kasumi-1 cells were grown in RPMI1640 supplemented with 10% foetal calf serum and 2 mM glutamine

extract_protocol: RNA was extracted with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.

treatment_protocol: Kasumi-1 cells were electroporated with 200 nM of either RUNX1/ETO siRNA (siRE) or mismatch siRNA (siMM) in three to four day intervals.

tag: cell line

tag: disease

value: Acute myeloid leukaemia

tag: sirna

value: RUNX1/ETO mismatch control

tag: time

value: 72 h after 3rd electroporation


title: Patient 71017; stage IB; Adenosquamous

source_name: Patient 71017


title: ZG46B_4

city: Ploen

first: Till

last: Czypionka

address: August-Thienemann-Strasse 2

department: Evolutionary Genetics

country: Germany

institute: MPI for Evolutionary Biology

hyb_protocol: The microarray was loaded with labeled cRNA as described in the Agilent protocol for One-Color Microarray-Based Gene Expression Analysis (version 6.5, May 2010).

scan_protocol: Microarrays were scanned with an Agilent DNA Microarray Scanner type C with the standard settings for 8 x 15 k Agilent expression arrays.

data_processing: Feature extraction was carried out using the Agilent Feature Extraction software (version 10.7.3.1) and the “gprocessed signal” was taken in the measure for signal intensity. We employed a new normalization procedure, which relates changes in signal intensity to changes in transcript abundance, thereby accounting for observed large differences in probe-binding behavior. This procedure translates measured signal intensities to a percentage of the target transcript’s abundance in a pool previously used for the calibration of the array. Based on this value, new theoretical signal intensity values are calculated based on the same previous calibration. These new theoretical signal intensity values are then normalized for interarray normalization by division by the 75%tile as suggested by Agilent. For a detailed account of the new normalization procedure, please refer to the accompanying publication (Czypionka et al. 2011.Transcriptome changes after genome wide admixture in invasive sculpins Molecular Ecology; no doi yet).

organism: Cottus

source_name: whole fish

label_protocol: Labeled cRNA was prepared from total RNA using the Agilent Low Input Quick Amp Labeling kit.

extract_protocol: Whole fishes were homogenized with a Qiagen Tissue Ruptur  and total RNA was extracted following the Trizol protocol (Invitrogen). Total RNA was quality accessed using an RNA Nano Chip (Agilent) which a was also used for quantification. Quantification was additionally carried out using a NanoDrop-1000 spectrophotometer

tag: species/hybrid

value: F2 crosses

tag: population

value: F2 Broel-WN

tag: type

tag: rearing environment

value: lab reared


title: Blood, subject 10897903, hours since injury 169.3

source_name: Subject 10897903, hours since injury 169.3

value: White Blood Cells

value: M


title: ZG46B_3


title: Patient 70867; stage IB; AD

source_name: Patient 70867

value: non-small cell lung cancer (NSCLC)

value: IB


title: ZG46B_2


title: Blood, subject 10821928, hours since injury 21.7

source_name: Subject 10821928, hours since injury 21.7


title: siRE_D10_L

description: 72 h after 3rd electroporation

source_name: RUNX1/ETO knock-down 240h

value: RUNX1/ETO knock-down


title: siRE_D7_I

description: 72 h after 2nd electroporation

source_name: RUNX1/ETO knock-down 168h

value: 72 h after 2nd electroporation


title: siRE_D2_K

description: 48 h after 1st electroporation

source_name: RUNX1/ETO knock-down 48h

value: 48 h after 1st electroporation


title: ZG46B_1


title: siRE_D4_J

description: 96 h after 1st electroporation

source_name: RUNX1/ETO knock-down 96h

value: 96 h after 1st electroporation


title: Patient 281; stage IB; AD

source_name: Patient 281

value: AD

value: Male


title: Patient 71015; stage IB; AD

source_name: Patient 71015

value: Female


title: siMM_D4_A

description: 96 h after 1st electroporation

source_name: RUNX1/ETO mismatch control 96h

value: Acute myeloid leukaemia


title: ZG39_4

value: F2 Naaf-LB


title: Blood, subject 10771530, hours since injury 161.2

source_name: Subject 10771530, hours since injury 161.2


title: Blood, subject 10771530, hours since injury 39.2

source_name: Subject 10771530, hours since injury 39.2


title: siMM_D7_G

description: 72 h after 2nd electroporation

source_name: RUNX1/ETO mismatch control 168h

value: RUNX1/ETO mismatch control


title: Blood, subject 10821928, hours since injury 137.8

source_name: Subject 10821928, hours since injury 137.8


title: Patient 377; stage IA; AD

source_name: Patient 377

value: IA


title: ZG39_3

value: F2 crosses


title: Blood, subject 10771530, hours since injury 112.1

source_name: Subject 10771530, hours since injury 112.1


title: Patient 130-b; stage IA; AD

source_name: Patient 130-b


title: siMM_D2_F

description: 48 h after 1st electroporation

source_name: RUNX1/ETO mismatch control 48h


title: Patient 409; stage IB; AD

source_name: Patient 409


title: Blood, subject 10771530, hours since injury 10.7

source_name: Subject 10771530, hours since injury 10.7


title: Patient 136; stage IB; AD

source_name: Patient 136


title: Blood, subject 10305925, hours since injury 92.6

source_name: Subject 10305925, hours since injury 92.6

value: F


title: ZG38_4

source_name: whole fish

value: lab reared


title: ZG39_1


title: Patient 70826; stage IB; AD

source_name: Patient 70826


title: ZG39_2


title: Patient 271; stage IB; AD

source_name: Patient 271


title: ZG38_3


title: ZG38_1


title: Blood, subject 10305925, hours since injury 330.2

source_name: Subject 10305925, hours since injury 330.2

value: White Blood Cells


title: Patient 387; stage IA; AD

source_name: Patient 387

value: non-small cell lung cancer (NSCLC)


title: Blood, subject 10305925, hours since injury 496.3

source_name: Subject 10305925, hours since injury 496.3


title: ZG11_3

value: F2 Broel-WN


title: Patient 376; stage IA; AD

source_name: Patient 376


title: Blood, subject 11191616, hours since injury 22.5

source_name: Subject 11191616, hours since injury 22.5


title: ZG11_4


title: ZG11_2


title: Blood, subject 10290800, hours since injury 20

source_name: Subject 10290800, hours since injury 20

value: M


title: Blood, subject 10305925, hours since injury 6.4

source_name: Subject 10305925, hours since injury 6.4


title: Blood, subject 10290800, hours since injury 502.5

source_name: Subject 10290800, hours since injury 502.5


title: Blood, subject 10290800, hours since injury 7.3

source_name: Subject 10290800, hours since injury 7.3


title: Patient 197; stage IB; Adenosquamous

source_name: Patient 197

value: IB

value: Adenosquamous


title: ZG38_2


title: Blood, subject 10305925, hours since injury 159.7

source_name: Subject 10305925, hours since injury 159.7


title: Patient 371; stage IA; AD

source_name: Patient 371


title: Blood, subject 10305925, hours since injury 15.8

source_name: Subject 10305925, hours since injury 15.8


title: ZG11_1


title: WN_8

organism: Cottus perifretum

value: Cottus perifretum

value: Witte Nete (WN)

value: parental


title: Blood, subject 10290800, hours since injury 117.8

source_name: Subject 10290800, hours since injury 117.8


title: Blood, subject 10290800, hours since injury 171.8

source_name: Subject 10290800, hours since injury 171.8


title: Patient  101180; stage IB; AD

source_name: Patient  101180

value: AD

value: Male


title: Patient 401; stage IB; AD

source_name: Patient 401

value: Female


title: Blood, subject 10208165, hours since injury 91.1

source_name: Subject 10208165, hours since injury 91.1


title: WN_7

source_name: whole fish


title: Patient  71014; stage IA; SCC

source_name: Patient  71014

value: SCC


title: WN_6


title: WN_5


title: Patient  70818; stage IA; AD

source_name: Patient  70818

value: IA


title: Patient  124; stage IA; AD

source_name: Patient  124


title: WT brain, biological rep4

city: Chicago

first: Margaret

middle: Gail

last: Distler

state: IL

department: Department of Human Genetics

institute: University of Chicago

hyb_protocol: The details for the hyb/wash/stain are in the Affy protocol: http://media.affymetrix.com/support/downloads/manuals/wt_term_label_ambion_user_manual.pdf.  Briefly, the hybridization cocktail was made with the Affy Hyb buffer, DMSO, Oligo B2, and 20X eukaryotic controls and hybridized to the gene arrays for 17hrs at 45C. The arrays were then washed and stained with SAPE (Streptavidin Phycoerythrin binds to the biotin) and scanned.

scan_protocol: Affymetrix GeneChip Scanner 3000 7G

data_processing: Affymetrix Gene Expression Console Software (v 1.1.2)

organism: Mus musculus

source_name: Adult WT mouse whole brain

label_protocol: Standard Affymetrix protocol

growth_protocol: Mice were group housed and aged to adulthood

extract_protocol: RNA isolation with TRIzol and clean up with Qiagen RNeasy kit

treatment_protocol: Mice were all naïve and were not treated

tag: strain background

value: male

value: wild type

value: adult

value: whole brain


title: WT brain, biological rep5

tag: tissue


title: Blood, subject 10208165, hours since injury 4.8

source_name: Subject 10208165, hours since injury 4.8

value: White Blood Cells

tag: Sex

value: F


title: Blood, subject 10208165, hours since injury 163.3

source_name: Subject 10208165, hours since injury 163.3

tag: age


title: WT brain, biological rep3


title: WN_3

value: lab reared


title: Patient  163; stage IA; AD

data_processing: The data were normalised using quantile normalisation

source_name: Patient  163

tag: disease state

value: non-small cell lung cancer (NSCLC)


title: WN_4


title: Patient  181; stage IB; SCC

source_name: Patient  181

tag: patient id

value: IB


title: Patient  195; stage IA; SCC

source_name: Patient  195

tag: Stage


title: Blood, subject 1103804, hours since injury 112

source_name: Subject 1103804, hours since injury 112

value: M


title: Blood, subject 10208165, hours since injury 21.3

source_name: Subject 10208165, hours since injury 21.3


title: WT brain, biological rep2


title: Blood, subject 10118259, hours since injury 4.5

source_name: Subject 10118259, hours since injury 4.5


title: Patient  375; stage IA; AD

source_name: Patient  375

tag: subtype


title: Patient  101184-b; stage IB; AD

source_name: Patient  101184-b

tag: gender


title: WN_1

value: Cottus perifretum

value: Witte Nete (WN)


title: Blood, subject 10118259, hours since injury 17.3

source_name: Subject 10118259, hours since injury 17.3


title: Sieg_8

value: invasive hybrid lineage

value: Sieg

value: invasive

value: wild reared


title: WN_2

value: parental


title: Tg brain, biological rep5

source_name: Adult Tg mouse whole brain

value: male

value: Glo1 overexpression


title: Blood, control 10689045

source_name: Control


title: Tg brain, biological rep4

value: adult


title: Sieg_7

source_name: whole fish


title: WT brain, biological rep1

value: wild type

value: whole brain


title: Patient  400; stage IA; SCC

source_name: Patient  400

value: IA

value: SCC

value: Male


title: Blood, control 17043147

value: White Blood Cells

value: F


title: Blood, control 17268143

value: M


title: Tg brain, biological rep2


title: Patient  72010; stage IA; AD

source_name: Patient  72010

value: non-small cell lung cancer (NSCLC)

value: AD

value: Female


title: Tg brain, biological rep3


title: Sieg_6

value: invasive hybrid lineage

value: Sieg

value: invasive


title: Blood, control 16912123-2


title: Sieg_5

value: wild reared


title: Tg brain, biological rep1

value: male

value: Glo1 overexpression


title: Patient  70909; stage IB; SCC

source_name: Patient  70909

value: IB


title: Patient  70795; stage IB; AD

source_name: Patient  70795


title: Blood, control 7474474


title: Sieg_4


title: 13302337 - pool_Col vs pool_As

city: evry

first: Soubigou-Taconnat

last: Ludivine

address: 2 rue gaston crémieux

department: URGV

country: France

institute: INRA

description: Antisens and mutnats of the SKP2 and CUL4 genes are comprared to the Wt in order to identify the genes controled by those SCF proteins.

hyb_protocol: pool_As Cy5 / pool_Col Cy3 : 30pmol. (Hybridization_Protocol.txt) Hybridization Protocol: CATMA slides (Corning Microarray Technology, CORNING) are pretreated in the prehybridisation solution (1 % BSA, 0.1 SDS, 5X SSC ) at 42°C for 60 min. They are dipped a couple of times in distilled water at room temperature, then in isopropanol and dried immediately by compressed nitrogen stream. Slides were placed in Corning hybridization chambers with a 25x60 lifterslip and 10ul of distilled water for each groove. The target was diluted to a final volume of 60 µL as follows 15µl of purified, labeled cDNA, 15 µl of 4X Hybridization Buffer ( 20X SDS, 0.4 % SDS), 30 µL formamide. The target mixture is heated for 3 min at 95°C, put on ice for 30 sec and centrifuged to remove dust for 1 min. The target mixture was put on the chip as quickly as possible. The microarray is sealed in a chamber and submerged in a 42°C water bath for approximately 16 h. The microarray is washed for 4 min in 1xSSC, 0.2% SDS (42°C); 4 min in 0.1x SSC, 0.2% SDS (RT); 4 min in 0.1x SSC, 0.2% SDS (RT); 4 min in 0.1x SSC (RT); dipped a few times in distilled water and dried immediately by compressed nitrogen stream.

scan_protocol: GenePix Pro 3.0, Cy3:pmt voltage 532nm,650V,laser power 100%, Cy5:635nm,pmt voltage 620V,laser power 100%

data_processing: The raw data comprised the logarithm of median feature pixel intensity at wavelength 635 nm (red) and 532 nm (green). No background was subtracted. An array-by-array normalization was performed to remove systematic biases. First, we excluded spots that were considered badly formed features by the experimenter (Flags=-100). Then we performed a global intensity-dependent normalization using the loess procedure (see Yang et al., 2002) to correct the dye bias. Finally, on each block, the log-ratio median is subtracted from each value of the log-ratio of the block to correct a print-tip effect on each metablock.

organism: Arabidopsis thaliana

label_protocol: labelling Cy3 and Cy5 direct, amplification=yes, aRNA 5 ug. (Labelling_protocol.txt) Labelling protocol: 5 µg of aRNA (8µl) mixed with 2 µl of random nonamers 1µg/µl and 0.5 µl of RNAse Out 40 U/µl, denatured 10 min at 70 °C and chilled on ice. The followig components were added to the sample 4 µl of first strand buffer 5 X, 1 µl of 10 mM dNTP/2mM dCTP, 2 µl of 0.1 M DTT, 1.5 µl of Cy3-dCTP or Cy5-dCTP (Amersham Pharmacia Biotech, 25nmol tube, PA5502), 1 µl of SuperScript II RT 200U/µl. Then it was incubated at 42°C for 2.5 hours and chilled on ice. The sample was denaturated by adding 2 µl of NaOH 2.5M and incubated at 37 °C for exactly 15 min, then was added 10 µl of 2M MOPS and put on ice. The dyes were purified with the QIAquick PCR Purification Kit (QIAGEN).

growth_protocol: whole plant - The seeds have been sown every two days on MS 255 (Duschefa) without 1% sugar. These plates stayed 6 days in the dark at 4 °s. Then they were transfered to the light for 6 more days.

extract_protocol: Pool of extract, As1:700ng, As2:700ng, As3:700ng. (Qiagen_RNeasy.pdf)

treatment_protocol: no treatment

tag: ecotype

value: columbia

tag: genotype/variation

value: antisense

tag: treatment

extract_protocol: Pool of extract, Col1:700ng, Col2:700ng, Col3:700ng. (Qiagen_RNeasy.pdf)

value: wild type


title: Blood, control 26878554


title: Patient  102; stage IA; AD

source_name: Patient  102

value: IA


title: Patient  135; stage IA; AD

source_name: Patient  135

value: Male


title: 13302334 - pool_As vs pool_Col

hyb_protocol: pool_Col Cy5 / pool_As Cy3 : 30pmol. (Hybridization_Protocol.txt) Hybridization Protocol: CATMA slides (Corning Microarray Technology, CORNING) are pretreated in the prehybridisation solution (1 % BSA, 0.1 SDS, 5X SSC ) at 42°C for 60 min. They are dipped a couple of times in distilled water at room temperature, then in isopropanol and dried immediately by compressed nitrogen stream. Slides were placed in Corning hybridization chambers with a 25x60 lifterslip and 10ul of distilled water for each groove. The target was diluted to a final volume of 60 µL as follows 15µl of purified, labeled cDNA, 15 µl of 4X Hybridization Buffer ( 20X SDS, 0.4 % SDS), 30 µL formamide. The target mixture is heated for 3 min at 95°C, put on ice for 30 sec and centrifuged to remove dust for 1 min. The target mixture was put on the chip as quickly as possible. The microarray is sealed in a chamber and submerged in a 42°C water bath for approximately 16 h. The microarray is washed for 4 min in 1xSSC, 0.2% SDS (42°C); 4 min in 0.1x SSC, 0.2% SDS (RT); 4 min in 0.1x SSC, 0.2% SDS (RT); 4 min in 0.1x SSC (RT); dipped a few times in distilled water and dried immediately by compressed nitrogen stream.


title: Sieg_2

value: lab reared